BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11207431)

  • 1. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.
    Pérez-Torres S; Miró X; Palacios JM; Cortés R; Puigdoménech P; Mengod G
    J Chem Neuroanat; 2000 Dec; 20(3-4):349-74. PubMed ID: 11207431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
    Iona S; Cuomo M; Bushnik T; Naro F; Sette C; Hess M; Shelton ER; Conti M
    Mol Pharmacol; 1998 Jan; 53(1):23-32. PubMed ID: 9443929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.
    Bolger GB; Erdogan S; Jones RE; Loughney K; Scotland G; Hoffmann R; Wilkinson I; Farrell C; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):539-48. PubMed ID: 9371713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
    Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
    Richter W; Jin SL; Conti M
    Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
    Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs.
    Miró X; Pérez-Torres S; Palacios JM; Puigdomènech P; Mengod G
    Synapse; 2001 Jun; 40(3):201-14. PubMed ID: 11304758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
    Farooqui SM; Zhang K; Makhay M; Jackson K; Farooqui SQ; Cherry JA; O'Donnell JM
    Brain Res; 2000 Jun; 867(1-2):52-61. PubMed ID: 10837797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
    Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
    Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
    Torphy TJ; Zhou HL; Foley JJ; Sarau HM; Manning CD; Barnette MS
    J Biol Chem; 1995 Oct; 270(40):23598-604. PubMed ID: 7559525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
    Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
    Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
    Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
    Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: an autoradiographic study.
    Kato H; Araki T; Chen T; Itoyama Y; Kogure K
    Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):403-8. PubMed ID: 9701778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
    Landells LJ; Szilagy CM; Jones NA; Banner KH; Allen JM; Doherty A; O'Connor BJ; Spina D; Page CP
    Br J Pharmacol; 2001 Jul; 133(5):722-9. PubMed ID: 11429397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 May; 305(2):565-72. PubMed ID: 12704225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
    MacKenzie SJ; Houslay MD
    Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.